![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/30/2938472/0/en/HOOKIPA-Pharma-Announces-Board-of-Directors-Changes.html
https://www.globenewswire.com/news-release/2024/08/28/2937024/0/en/HOOKIPA-Pharma-to-Participate-in-the-H-C-Wainwright-26th-Annual-Global-Investment-Conference.html
https://www.globenewswire.com/news-release/2024/08/08/2927424/0/en/HOOKIPA-Pharma-Reports-Second-Quarter-2024-Financial-Results-and-Recent-Business-Highlights.html
https://www.globenewswire.com/news-release/2024/07/22/2916520/0/en/HOOKIPA-Pharma-Announces-Leadership-Changes-to-Intensify-Focus-on-HB-200.html
https://www.globenewswire.com/news-release/2024/07/08/2909514/0/en/HOOKIPA-Pharma-Announces-Effective-Date-of-1-for-10-Reverse-Stock-Split.html
https://www.globenewswire.com/news-release/2024/07/01/2907081/0/en/HOOKIPA-Pharma-Announces-First-Person-Dosed-in-Phase-1b-Clinical-Trial-of-HB-500-for-the-Treatment-of-HIV.html
https://www.globenewswire.com/news-release/2024/06/04/2893345/0/en/HOOKIPA-Pharma-Announces-Updated-Phase-2-Clinical-Data-at-the-American-Society-of-Clinical-Oncology-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/05/30/2891156/0/en/HOOKIPA-Pharma-to-Host-Investor-Call-on-HB-200-Data-Presented-at-American-Society-of-Clinical-Oncology-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/05/23/2887693/0/en/HOOKIPA-Pharma-Announces-Positive-Clinical-Data-to-be-Presented-at-the-American-Society-for-Clinical-Oncology-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/05/09/2878623/0/en/HOOKIPA-Pharma-Reports-First-Quarter-2024-Financial-Results-and-Recent-Business-Highlights.html